Archives of Dermatological Research

, Volume 301, Issue 3, pp 197–203

Management of atopic dermatitis using photo(chemo)therapy

Review Article

Abstract

The conclusions that may be drawn by interpreting the current literature on the efficacy of photo(chemo)therapy in the treatment of atopic dermatitis (AD) are limited by several factors including publication bias, small sample sizes, high variability of parameters used in different studies, and in particular the lack of randomized controlled trials comparing different photo(chemo)therapeutic modalities. The newer ultraviolet (UV) modalities, such as medium-dose UVA1 and narrowband (NB) UVB, with a high output and a narrow emission spectrum may be considered the probably most efficacious regimens for treating acute and chronic AD, respectively, in particular when compared to conventional broadband UV regimens. There are no prospective trials on AD patients comparing NB UVB and UVA1 with more complex regimens such as heliotherapy, balneophototherapy, psoralen plus UVA (PUVA), and extracorporeal photophoresis. Support for the role of the aforementioned regimens in the treatment of AD is generally weaker than for the newer modalities including medium-dose UVA1 and NB UVB. When photo(chemo)therapy is considered for AD patients, its use is very much dedicated by the cost-effectiveness, availability, and the practicality of attending the clinic several times a week.

Keywords

Atopic eczema Phototherapy Photochemotherapy Ultraviolet A1 Narrow-band UVB 

References

  1. 1.
    Abeck D, Schmidt T, Fesq H, Strom K, Mempel M, Brockow K, Ring J (2000) Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 42:254–257. doi:10.1016/S0190-9622(00)90134-8 PubMedCrossRefGoogle Scholar
  2. 2.
    Atherton DJ, Carabott F, Glover MT, Hawk JL (1988) The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents. Br J Dermatol 118:791–795. doi:10.1111/j.1365-2133.1988.tb02597.x PubMedCrossRefGoogle Scholar
  3. 3.
    Autio P, Komulainen P, Larni HM (2002) Heliotherapy in atopic dermatitis: a prospective study on climatotherapy using the SCORAD index. Acta Derm Venereol 82:436–440. doi:10.1080/000155502762064575 PubMedCrossRefGoogle Scholar
  4. 4.
    Collins P, Ferguson J (1995) Narrowband (TL-01) UVB air-conditioned phototherapy for atopic eczema in children. Br J Dermatol 133:653–667. doi:10.1111/j.1365-2133.1995.tb02725.x PubMedCrossRefGoogle Scholar
  5. 5.
    Dawe RS (2003) Ultraviolet A1 phototherapy. Br J Dermatol 148:626–637. doi:10.1046/j.1365-2133.2003.05261.x PubMedCrossRefGoogle Scholar
  6. 6.
    De Kort WJ, van Weelden H (2000) Bath psoralen-ultraviolet A therapy in atopic eczema. J Eur Acad Dermatol Venereol 14:172–174. doi:10.1046/j.1468-3083.2000.00067.x PubMedCrossRefGoogle Scholar
  7. 7.
    Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A (2000) Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 142:39–43. doi:10.1046/j.1365-2133.2000.03239.x PubMedCrossRefGoogle Scholar
  8. 8.
    Dittmar HC, Pflieger D, Schempp CM, Schöpf E (1999) Comparison of balneophototherapy and UVA/B mono-phototherapy in patients with subacute atopic dermatitis. Hautarzt 50:649–653. doi:10.1007/s001050050975 PubMedCrossRefGoogle Scholar
  9. 9.
    Gambichler T (2007) Balneophototherapy for psoriasis using saltwater baths and UV-B irradiation, revisited. Arch Dermatol 143:647–649. doi:10.1001/archderm.143.5.647 PubMedCrossRefGoogle Scholar
  10. 10.
    Gambichler T, Küster W, Kreuter A, Altmeyer P, Hoffmann K (2000) Balneophototherapy—combined treatment of psoriasis vulgaris and atopic dermatitis with salt water baths and artificial ultraviolet radiation. J Eur Acad Dermatol Venereol 14:425–428. doi:10.1046/j.1468-3083.2000.00102-4.x PubMedCrossRefGoogle Scholar
  11. 11.
    Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A (2005) Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol 52:660–670. doi:10.1016/j.jaad.2004.08.047 PubMedCrossRefGoogle Scholar
  12. 12.
    Gambichler T, Othlinghaus N, Tomi NS, Holland-Letz T, Boms S, Skrygan M, Altmeyer P, Kreuter A (2008) Medium-dose ultraviolet (UV) A1 versus narrowband UVB phototherapy in atopic eczema: a randomised crossover study. Br J Dermatol. doi:10.1111/j.1365-2133.2008.08984.x
  13. 13.
    George SA, Bilsland DJ, Johnson BE, Ferguson J (1993) Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 128:49–56. doi:10.1111/j.1365-2133.1993.tb00147.x PubMedCrossRefGoogle Scholar
  14. 14.
    Hannuksela M, Karvonen J, Husa M, Jokela R, Katajamäki L, Leppisaari M (1985) Ultraviolet light therapy in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 114:137–139Google Scholar
  15. 15.
    Harari M, Shani J, Seidl V, Hristakieva E (2000) Climatotherapy of atopic dermatitis at the Dead Sea: demographic evaluation and cost-effectiveness. Int J Dermatol 39:59–69. doi:10.1046/j.1365-4362.2000.00840.x PubMedCrossRefGoogle Scholar
  16. 16.
    Hjierpe M, Hasan T, Salsala I, Reunala T (2001) Narrow-band UVB treatment in atopic dermatitis. Acta Derm Venereol 81:439–440. doi:10.1080/000155501317208462 CrossRefGoogle Scholar
  17. 17.
    Horio T (1998) Skin disorders that improve by exposure to sunlight. Clin Dermatol 16:59–65. doi:10.1016/S0738-081X(97)00170-3 PubMedCrossRefGoogle Scholar
  18. 18.
    Hudson-Peacock MJ, Diffey BL, Farr PM (1996) Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 135:332. doi:10.1111/j.1365-2133.1996.tb01179.x PubMedCrossRefGoogle Scholar
  19. 19.
    Jekler J, Larkö O (1990) The effect of ultraviolet radiation with peaks at 300 nm and 350 nm in the treatment of atopic dermatitis. Photodermatol Photoimmunol Photomed 7:169–172PubMedGoogle Scholar
  20. 20.
    Jekler J, Larkö O (1990) Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. J Am Acad Dermatol 22:49–53. doi:10.1016/0190-9622(90)70006-4 PubMedCrossRefGoogle Scholar
  21. 21.
    Jekler J, Larkö O (1991) Phototherapy for atopic dermatitis with ultraviolet A (UVA), low-dose UVB and combined UVA and UVB: two paired-comparison studies. Photodermatol Photoimmunol Photomed 8:151–156PubMedGoogle Scholar
  22. 22.
    Katagiri K, Arakawa S, Hatano Y, Fujiwara S (2008) Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin. Arch Dermatol Res 300:583–593PubMedCrossRefGoogle Scholar
  23. 23.
    Kowalzick L, Kleinheinz A, Weichenthal M, Neuber K, Köhler I, Grosch J, Lungwitz G, Seegeberg C, Ring J (1995) Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol 75:43–45PubMedGoogle Scholar
  24. 24.
    Krutmann J (2000) Phototherapy for atopic dermatitis. Clin Exp Dermatol 25:552–558. doi:10.1046/j.1365-2230.2000.00700.x PubMedCrossRefGoogle Scholar
  25. 25.
    Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E (1992) High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 26:225–230. doi:10.1016/0190-9622(92)70031-A PubMedCrossRefGoogle Scholar
  26. 26.
    Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sönnichsen N, Czech W, Kapp A, Stege H, Grewe M, Schöpf E (1998) High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 38:589–593. doi:10.1016/S0190-9622(98)70123-9 PubMedCrossRefGoogle Scholar
  27. 27.
    Larkö O (1996) Phototherapy of eczema. Photodermatol Photoimmunol Photomed 12:91–94PubMedGoogle Scholar
  28. 28.
    Lee E, Koo J, Berger T (2005) UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol 44:355–360. doi:10.1111/j.1365-4632.2004.02186.x PubMedCrossRefGoogle Scholar
  29. 29.
    Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, Wolf P (2003) Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 139:223–224. doi:10.1001/archderm.139.2.223 PubMedCrossRefGoogle Scholar
  30. 30.
    Majoie IM, Oldhoff JM, van Weelden H, Laaper-Ertmann M, Bousema MT, Sigurdsson V, Knol EF, Bruijnzeel-Koomen CA, de Bruin-Weller MS (2009) Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 60:77–84PubMedCrossRefGoogle Scholar
  31. 31.
    Meduri NB, Vandergriff T, Rasmussen H, Jacobe H (2007) Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 23:106–112. doi:10.1111/j.1600-0781.2007.00291.x PubMedCrossRefGoogle Scholar
  32. 32.
    Midelfart K, Stenvold SE, Volden G (1985) Combined UVB and UVA phototherapy of atopic eczema. Dermatologica 171:95–98PubMedCrossRefGoogle Scholar
  33. 33.
    Mori H, Yamanaka K, Matsuo K, Kurokawa I, Yasutomi Y, Mizutani H (2008) Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells. Arch Dermatol Res (Epub ahead of print)Google Scholar
  34. 34.
    Polderman MCA, Wintzen M, le Cessie S, Pavel S (2005) UVA-1 cold light therapy in the treatment of atopic dermatitis: 61 patients treated in the Leiden University Medical Center. Photodermatol Photoimmunol Photomed 21:93–96. doi:10.1111/j.1600-0781.2005.00150.x PubMedCrossRefGoogle Scholar
  35. 35.
    Prinz B, Michelsen S, Pfeiffer C, Plewig G (1999) Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis. J Am Acad Dermatol 40:577–582. doi:10.1016/S0190-9622(99)70440-8 PubMedCrossRefGoogle Scholar
  36. 36.
    Radenhausen M, Michelsen S, Plewig G, Bechara FG, Altmeyer P, Hoffmann K (2004) Bicentre experience in the treatment of severe generalised atopic dermatitis with extracorporeal photochemotherapy. J Dermatol 31:961–9670PubMedGoogle Scholar
  37. 37.
    Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM (2001) Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 357:2012–2016. doi:10.1016/S0140-6736(00)05114-X PubMedCrossRefGoogle Scholar
  38. 38.
    Richter HI, Billmann-Eberwein C, Grewe M, Stege H, Berneburg M, Ruzicka T, Krutmann J (1998) Successful monotherapy of severe and intractable atopic dermatitis by photopheresis. J Am Acad Dermatol 38:585–588. doi:10.1016/S0190-9622(98)70122-7 PubMedCrossRefGoogle Scholar
  39. 39.
    Sand M, Bechara FG, Sand D, Radenhausen M, Tomi NS, Altmeyer P, Hoffmann K (2007) Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis. Dermatology 215:134–138. doi:10.1159/000104265 PubMedCrossRefGoogle Scholar
  40. 40.
    Scheinfeld NS, Tutrone WD, Weinberg JM, DeLeo VA (2003) Phototherapy of atopic dermatitis. Clin Dermatol 21:241–248. doi:10.1016/S0738-081X(02)00364-4 PubMedCrossRefGoogle Scholar
  41. 41.
    Schiffner R, Schiffner-Rohe J, Gerstenhauer M, Landthaler M, Hofständer F, Stolz W (2002) Dead Sea treatment—principle for outpatient use in atopic dermatitis: safety and efficacy of synchronous balneophototherapy using narrowband UVB and bathing in Dead Sea salt solution. Eur J Dermatol 12:543–548PubMedGoogle Scholar
  42. 42.
    Sheehan MP, Atherton DJ, Norris P, Hawk J (1993) Oral psoralen photochemotherapy in severe childhood atopic eczema: an update. Br J Dermatol 129:431–436. doi:10.1111/j.1365-2133.1993.tb03171.x PubMedCrossRefGoogle Scholar
  43. 43.
    Stern RS, PUVA Follow up Study (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44:755–761. doi:10.1067/mjd.2001.114576 PubMedCrossRefGoogle Scholar
  44. 44.
    Tzaneva S, Seeber A, Schwaiger M, Hönigsmann H, Tanew A (2001) High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 45:503–507. doi:10.1067/mjd.2001.114743 PubMedCrossRefGoogle Scholar
  45. 45.
    Uetsu N, Horio T (2003) Treatment of persistent severe atopic dermatitis in 113 Japanese patients with oral psoralen photo-chemotherapy. J Dermatol 30:450–457PubMedGoogle Scholar
  46. 46.
    Valkova S, Velkova A (2004) UVA/UVB phototherapy for atopic dermatitis revisited. J Dermatolog Treat 15:239–244. doi:10.1080/09546630410035338 PubMedCrossRefGoogle Scholar
  47. 47.
    von Kobyletzki G, Pieck C, Hoffmann K, Freitag M, Altmeyer P (1999) Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 41:931–937. doi:10.1016/S0190-9622(99)70249-5 CrossRefGoogle Scholar
  48. 48.
    Weischer M, Blum A, Eberhard F, Röcken M, Berneburg M (2004) No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol 84:370–374. doi:10.1080/00015550410026948 PubMedCrossRefGoogle Scholar
  49. 49.
    Yoshiike T, Aikawa Y, Sindhvananda J, Ogawa H (1993) A proposed guideline for psoralen photochemotherapy (PUVA) with atopic dermatitis: successful therapeutic effect on severe and intractable cases. J Dermatol Sci 5:50–53. doi:10.1016/0923-1811(93)90105-X PubMedCrossRefGoogle Scholar
  50. 50.
    Zimmermann J, Utermann S (1994) Photosoletherapie bei Patienten mit Psoriasis und Neurodermitis atopica. Hautarzt 45:849–853. doi:10.1007/s001050050184 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Department of DermatologyRuhr-University BochumBochumGermany

Personalised recommendations